General Info
Jeroen Cammeraat is the CEO of i-Optics, with over 20 years of global experience in the medical technology and life sciences market. His investment focus areas include the creation of ecosystems and going upmarket. He typically invests in Seed & Series A stages, preferring industry agnosticism, excluding guns and gambling. His geographical focus is open to all regions, with a priority on identified geographies with the best opportunities. Jeroen’s investment thesis emphasizes the potential of ecosystem creation, going upmarket, product stickiness, addressing the large but not apparent market, and founder commitment as a key differentiator.
Location: The Hague, Zuid-Holland, The Netherlands
Country: Netherlands
Industries:
Investment Regions: EU
Investment Stages: pre-seed, seed
angel-individual
EU
Want to start building warm intros with this investor?
🤖 AI Activity Report
Status: low-active
AI Reasoning: Source data shows the investor’s last known investment was in i-Optics (Series C) on Oct 28, 2010. Calculating from today, the time since last investment is well over 12 years, which exceeds 12 months, so assign the corresponding classification.
Angel activity thresholds:
Low Activity – Only known angel investments more than 12 months ago.
Active – Known angel investments between the last 12 and 6 months.
Very Active – Known angel investments in the last 6 months.
Investor Contact
Team Members
Name
Role
Email
LinkedIn
…
…
…
…
…
Investment Regions Map
loading map…
Similar Investors
Other similar investors:
Latest on X (Twitter)
Access all contact details of Jeroen Cammeraat
Gain instant access to partner names, verified emails, LinkedIn profiles, and more—all in one place. Dive into their portfolio founders and their LinkedIn information, so you can quickly start your outreach and look for warm intros.
Add custom tags to your investor cards. Label them by investment stage, industry focus, interest level, or any other criteria you want to stay organized.
Trusted by Founders like You
Find your matching investors using AI